Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Journal of the National Cancer Institute
|
August 22, 2025
The impact of eligibility criteria on KRASG12C inhibitor trials in patients with NSCLC
Margaux Wooster, Michael May, Prashasti Agrawal, et al.
Cell Reports. Medicine
|
December 13, 2022
Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors
Shoiab Bukhari, Brian S Henick, Robert J Winchester, et al.
Journal of Personalized Medicine
|
May 27, 2025
Central Nervous System Metastases from Primary Lung Carcinoma: Significance of RNA Fusion Testing and Early Versus Late Metastases
Michelle Garlin Politis, Mahesh Mansukhani, Benjamin O Herzberg, et al.
Journal for Immunotherapy of Cancer
|
December 25, 2024
Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings
Brian S Henick, Peter D Koch, Justin F Gainor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2019
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis
Ila Datar, Miguel F Sanmamed, Jun Wang, et al.
Nature Genetics
|
January 9, 2023
Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens
Yiping Wang, Joy Linyue Fan, Johannes C Melms, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients
A R Mato, B T Hill, N Lamanna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2019
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
K Hastings, H A Yu, W Wei, et al.
Journal for Immunotherapy of Cancer
|
June 19, 2026
First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors
Kristoffer Staal Rohrberg, Ignacio Melero, Miguel F Sanmamed, et al.
Nature Medicine
|
March 28, 2024
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
Amy R Rappaport, Chrisann Kyi, Monica Lane, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Journal of the National Cancer Institute
|
August 22, 2025
The impact of eligibility criteria on KRASG12C inhibitor trials in patients with NSCLC
Margaux Wooster, Michael May, Prashasti Agrawal, et al.
Cell Reports. Medicine
|
December 13, 2022
Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors
Shoiab Bukhari, Brian S Henick, Robert J Winchester, et al.
Journal of Personalized Medicine
|
May 27, 2025
Central Nervous System Metastases from Primary Lung Carcinoma: Significance of RNA Fusion Testing and Early Versus Late Metastases
Michelle Garlin Politis, Mahesh Mansukhani, Benjamin O Herzberg, et al.
Journal for Immunotherapy of Cancer
|
December 25, 2024
Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings
Brian S Henick, Peter D Koch, Justin F Gainor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2019
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis
Ila Datar, Miguel F Sanmamed, Jun Wang, et al.
Nature Genetics
|
January 9, 2023
Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens
Yiping Wang, Joy Linyue Fan, Johannes C Melms, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients
A R Mato, B T Hill, N Lamanna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2019
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
K Hastings, H A Yu, W Wei, et al.
Journal for Immunotherapy of Cancer
|
June 19, 2026
First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors
Kristoffer Staal Rohrberg, Ignacio Melero, Miguel F Sanmamed, et al.
Nature Medicine
|
March 28, 2024
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
Amy R Rappaport, Chrisann Kyi, Monica Lane, et al.
Page
of 5